Skip to main content
Year archive

PERCHERON THERAPEUTICS LIMITED — 2008 filings

All 50 regulatory filings released by PERCHERON THERAPEUTICS LIMITED (PER) in 2008, sourced directly from the official regulator.

50 Filings
2008 Period
2008 filings (50)
Filing Released Lang
ATL1103 Development on Schedule 1 page ?Kb
Capital/Financing Update
2008-12-16 English
New Appointment to support the ATL/TV1102 Licensing Program 1
Board/Management Information
2008-12-08 English
ATL1101 intellectual property portfolio strengthened 2 pages ?Kb
Regulatory Filings
2008-11-18 English
Change of Director`s Interest Notice - RM 2 pages ?Kb
Director's Dealing
2008-11-05 English
Change of Director`s Interest Notice - RM 2 pages ?Kb
Director's Dealing
2008-11-04 English
Annual General Meeting Presentation 30 pages ?Kb
AGM Information
2008-10-30 English
Results of 2008 Annual General Meeting 1 page ?Kb
Declaration of Voting Results & Voting Rights Announcements
2008-10-30 English
ANP to Present at Rodman and Renshaw Healthcare Conference 1
Investor Presentation
2008-10-27 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2008-10-26 English
Change of Director`s Interest Notice - GW, RM, MD, CB, GM 10 pages ?Kb
Director's Dealing
2008-10-26 English
ATL1101 Preclinical Data in Prostate Cancer-US Presentation 2 pages ?Kb
Investor Presentation
2008-10-16 English
ATL1101 suppresses tumours in prostate cancer animal study 3 pages ?Kb
Regulatory Filings
2008-10-14 English
Appendix 4C - Quarterly Cashflow Report 5 pages ?Kb
Interim / Quarterly Report
2008-10-13 English
Notice of Annual General Meeting 88 pages ?Kb
Annual Report
2008-09-23 English
ANP and Isis Investor Conference Call Webcast 5 pages ?Kb
Call Transcript
2008-09-21 English
Teva Pharmaceuticals Announcement re MS World Congress 4 pages ?Kb
Investor Presentation
2008-09-15 English
Investor Presentation 18 pages ?Kb
Investor Presentation
2008-09-09 English
ATL/TV1102 data to be presented at MS Scientific Meeting 2 pages ?Kb
Regulatory Filings
2008-08-27 English
Results of Meeting 1 page ?Kb
Declaration of Voting Results & Voting Rights Announcements
2008-08-25 English
Appendix 4E and Annual Financial Report 57 pages ?Kb
Regulatory Filings
2008-08-12 English
Market Update 1 page ?Kb
Capital/Financing Update
2008-08-04 English
Trading Halt 1 page ?Kb
Regulatory Filings
2008-08-03 English
Trading Halt Request 1 page ?Kb
Regulatory Filings
2008-08-03 English
Key journal highlights IGF-1R as high interest cancer target 1
Regulatory Filings
2008-07-30 English
Appendix 4C - Quarterly Cashflow Report 5 pages ?Kb
Interim / Quarterly Report
2008-07-23 English
Market Update 1 page ?Kb
Regulatory Filings
2008-07-22 English
Notice of General Meeting 19 pages ?Kb
Proxy Solicitation & Information Statement
2008-07-21 English
Notice of Meeting Clarification 1 page ?Kb
AGM Information
2008-07-21 English
ANP Business and Strategy Update 3 pages ?Kb
Capital/Financing Update
2008-07-20 English
Phase lla MS Trial Success - Teva to continue development 4 pages ?Kb
Capital/Financing Update
2008-06-29 English
Trading Halt 2 pages ?Kb
Regulatory Filings
2008-06-25 English
ANP to present to Isis Shareholders in the US 24 pages ?Kb
Investor Presentation
2008-06-01 English
ATL1103 On Path to Clinic with Start of Toxicology Studies 2 pages ?Kb
Capital/Financing Update
2008-05-05 English
Change in substantial holding 31 pages ?Kb
Major Shareholding Notification
2008-04-21 English
Notice under s708A(5)(e) 1 page ?Kb
Capital/Financing Update
2008-04-17 English
ANP completes ATL1102 Phase IIa Multiple Sclerosis Trial 2 pages ?Kb
Regulatory Filings
2008-04-16 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2008-04-16 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2008-04-15 English
Appendix 4C - quarterly 5 pages ?Kb
Interim / Quarterly Report
2008-04-07 English
ATL1102 Phase IIa Multiple Sclerosis Trial Update 1
Regulatory Filings
2008-03-31 English
Research Director Receives 2008 Advancing BioBusiness Award 5 pages ?Kb
Regulatory Filings
2008-03-25 English
Final Director`s Interest Notice - FB 2 pages ?Kb
Director's Dealing
2008-03-16 English
Resignation of Non-Executive Director 1 page ?Kb
Board/Management Information
2008-03-05 English
ANP to present at US Investor Conference 20 pages ?Kb
Investor Presentation
2008-02-21 English
Trading Halt 1 page ?Kb
Regulatory Filings
2008-02-10 English
ATL1102 Licensed to Teva Pharmaceuticals Ltd 2 pages ?Kb
Capital/Financing Update
2008-02-10 English
Market Update - MS drug Tysabri sales 1 page ?Kb
Regulatory Filings
2008-02-06 English
Half Year Accounts - 31 December 2007 17 pages ?Kb
Interim / Quarterly Report
2008-02-03 English
Quarterly Cashflow Report - 2nd Quarter 5 pages ?Kb
Interim / Quarterly Report
2008-01-22 English
Market Update-ANP Technology Partner and Major Shareholder 4 pages ?Kb
Capital/Financing Update
2008-01-07 English